KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Receivables - Other (2016 - 2024)

Historic Receivables - Other for Staar Surgical (STAA) over the last 11 years, with Q4 2024 value amounting to $27.5 million.

  • Staar Surgical's Receivables - Other changed N/A to $27.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $27.5 million, marking a year-over-year change of. This contributed to the annual value of $27.5 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Staar Surgical reported Receivables - Other of $27.5 million as of Q4 2024.
  • In the past 5 years, Staar Surgical's Receivables - Other registered a high of $27.5 million during Q4 2024, and its lowest value of $1000.0 during Q1 2020.
  • In the last 4 years, Staar Surgical's Receivables - Other had a median value of $5000.0 in 2021 and averaged $5.5 million.
  • Per our database at Business Quant, Staar Surgical's Receivables - Other tumbled by 9000.0% in 2020 and then skyrocketed by 88000.0% in 2021.
  • Over the past 4 years, Staar Surgical's Receivables - Other (Quarter) stood at $1000.0 in 2020, then skyrocketed by 4800.0% to $49000.0 in 2021, then crashed by 89.8% to $5000.0 in 2022, then skyrocketed by 549900.0% to $27.5 million in 2024.
  • Its Receivables - Other stands at $27.5 million for Q4 2024, versus $5000.0 for Q4 2022 and $49000.0 for Q4 2021.